Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Xsphera Biosciences Inc

Request full access

Precision ex vivo profiling to predict patient responses to oncology therapeutics

Cambridge, United StatesFounded 2018Biotech & Life Sciences

About Xsphera Biosciences Inc

Xsphera Biosciences Inc. specializes in predicting patient responses to oncology therapeutics using their advanced Tumor Microenvironment (TME) Platform. This platform preserves the complete tumor microenvironment from a biopsy, including immune cells, tumor cells, and stroma, within multiple microfluidic channels. Each channel can be treated with different therapies to measure cytotoxic efficacy and molecular response, providing a comprehensive analysis of therapeutic outcomes. The Intelligent Analytics platform integrates cloud-based software with laboratory environments to automatically ingest and analyze sample and treatment response data, including detailed patient immune profiles.

Xsphera Biosciences serves oncology researchers and pharmaceutical companies, operating in the precision medicine market. The business model is based on providing advanced profiling services and analytics to predict therapeutic responses, thus aiding in the development of personalized cancer treatments. Revenue is generated through service contracts with research institutions and pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
13
Open positions
None listed
Dealroom signal
67.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, slush24, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC May 2023 $13M $50M Undisclosed ↗
SEEDEquity / VC Nov 2020 $5M $20M Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Xsphera Biosciences Inc website traffic

Latest recorded traffic for Xsphera Biosciences Inc is 1.7K monthly website visits, up 400% over the last three months. Xsphera Biosciences Inc's team declined 18.8% over the past year.

Latest monthly visits1.7K 3-month web change+400% 1-year team growth-18.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Xsphera Biosciences Inc in the Cambridge ecosystem

Live from Dealroom

The Xsphera Biosciences Inc office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • Dana-Farber Cancer Institute
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States90%
🇯🇵 Japan10%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Xsphera Biosciences Inc on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xsphera Biosciences Inc’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.